Medullary Thyroid Cancer: A Different Thyroid Cancer, a Blood Test That Tracks It, and a Gene to Check

Last updated September 4, 2026.

Medullary thyroid cancer, MTC, is a cancer of the thyroid's C cells, which make the hormone calcitonin. It behaves differently from the common papillary thyroid cancer that dominates thyroid-cancer statistics: it does not take up iodine, so radioactive iodine does not touch it, but it offers something else, a blood marker that tracks it with remarkable precision. About three quarters of cases appear out of nowhere; the other quarter are inherited, and that possibility changes things for the whole family.

How it is found

The usual story is a lump in the neck or a nodule spotted on a scan, sometimes with stubborn diarrhea or flushing when the tumor's hormone output is high. Blood tests showing high calcitonin point strongly at MTC, and a needle sample confirms it. Scans then map whether it has moved to neck lymph nodes or beyond, because that shapes the operation.

Medullary thyroid cancer is tracked by a blood marker, treated with surgery, and in a quarter of cases inherited. The gene test matters because a carrier child can have the cancer prevented entirely.

Start a free AI doctor consult →

How it is treated

Surgery is the main event: removal of the whole thyroid plus the neck lymph nodes that look involved, and when the cancer is contained, that operation is often the cure. Afterward, the calcitonin level becomes the early warning system: it should fall to low or undetectable, and a rising level later is how recurrence announces itself, usually long before anything can be felt. When MTC does return or spread, it tends to move slowly, and there are targeted pills for the types driven by specific gene changes, plus other drug and radiation options for the cases that need them. Lifelong thyroid hormone replacement follows the surgery, as with any total thyroid removal.

The family question

A quarter of MTC is caused by an inherited change in a gene called RET, passed from parent to child with a one in two chance. Everyone diagnosed with MTC is offered genetic testing. If a RET change is found, close relatives are tested, and carriers can have the thyroid removed preventively in childhood, which essentially eliminates their risk of this cancer. If the test is negative, the case is sporadic and the family is off the hook. This is one of the few cancers where a blood-relative's diagnosis can be turned into prevention for the next generation.

Say yes to the genetic test. It is one blood draw, and it settles whether your children, siblings, and parents need testing. A positive result is not a verdict for them; it is a prevention plan.
Learn your calcitonin number. After surgery it is your personal tracker. Know the value, know the trend, and keep every follow-up blood draw.
Radioactive iodine is not part of this cancer's story. If you read thyroid cancer material that centers on iodine treatment, it is about the other cell type. MTC plays by different rules.

If you are weighing the risks and benefits of any medicine mentioned here, our overview of how medicines are tested and monitored for safety explains what those conversations are built on.

What a Pymander AI doctor consult looks like

I am 48 and just had my thyroid removed for medullary thyroid cancer. The surgeon thinks he got it all. Now they want to test me for the RET gene and my calcitonin every few months. My kids are 12 and 15. If I have this gene, are my kids going to get cancer?

If your test comes back positive, each of your children has a one in two chance of carrying the same change, and that sentence lands hard, so let me finish it: carrying the change is no longer a cancer sentence, because children found to carry RET can have their thyroid removed before cancer ever starts, at an age the specialists choose by the exact mutation, and that operation essentially eliminates this cancer from their story. That is the entire reason the test is offered, and it is one of the few places in cancer medicine where the family tree can be rewritten like that. The first step, though, is your own result: three quarters of medullary cases are sporadic, meaning no gene, no family risk, and your children need nothing. So the sequence is your blood draw, then only if positive, a gentle, planned testing conversation for the kids with a genetics team who does this constantly. On your own follow-up: the calcitonin checks are the best surveillance system in thyroid cancer, and a clean level after surgery is exactly what your surgeon is hoping to confirm. You are in the part of this disease where the plan mostly works.

Thanks for giving me all this information. A new cancer diagnosis plus a genetic question over your children is a heavy combination, and you are handling it in the right order: your surgery done, your marker being tracked, your gene test next. Your questions for the team: when will my RET result be back, what does my first post-surgery calcitonin show, and if the gene is found, who talks to the children and when. Whatever the result, there is a plan, and in the positive case the plan is one of the best prevention stories in medicine.

Care note

Post-surgery consult, 48M, RET testing pending, fear for children. The consult answers the gene question completely: one in two transmission, but childhood thyroidectomy converts carrier status into prevention. Sequencing matters (his result first) to keep 12- and 15-year-olds from being tested on a maybe. Calcitonin-as-tracker reinforced.

One in two and three quarters figures are standard. Preventive thyroidectomy described without age specifics because timing is mutation-specific. Sources: Cleveland 22873, MedlinePlus 000374 (title renders 'Thyroid cancer - medullary carcinoma' - flagged as technical-title, content correct). No chains, banned adverbs absent.

View care note →

Illustrative example, not a real member's messages.

Common questions

Is medullary thyroid cancer the same as regular thyroid cancer?

No. The common thyroid cancers come from hormone-making follicular cells and respond to radioactive iodine. Medullary comes from the C cells, ignores iodine, and is tracked by the calcitonin blood test instead. Treatment and follow-up differ accordingly.

What is the RET gene test for?

About a quarter of medullary thyroid cancer is inherited through a change in the RET gene. Your test result decides whether your relatives need testing. If positive, carriers in the family can have preventive thyroid removal that essentially eliminates this cancer for them.

Will I need radioactive iodine treatment?

No. Medullary cells do not take up iodine, so that treatment does not work for this type. Surgery is the main treatment, with targeted medicines and other options kept for recurrence or spread.

What happens if my calcitonin rises after surgery?

A rising calcitonin signals remaining or returning cancer, usually long before symptoms. The team then images to find where it is. Many recurrences move slowly and are watched or treated with targeted medicines; a rising number is information, not an emergency.

At what age would my children be tested or treated?

If your RET test is positive, children are offered genetic testing, and carriers are offered preventive thyroid removal at an age chosen by the specific mutation, some in early childhood, some later. A genetics team lays out the exact timeline for your family's mutation.

What is life like after total thyroid removal?

One daily thyroid hormone tablet replaces what the gland made, with periodic blood tests to tune the dose. Calcium can dip after this surgery, so some people take calcium and vitamin D, sometimes temporarily. Most people feel entirely normal once the dose is settled.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.